Erin Catherine Carter - Director at Glucotrack, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
GCTK on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Erin Catherine Carter since 20 Aug 2025

Reported holdings for Erin Catherine Carter in Glucotrack, Inc.

Form 4 holding Director

Glucotrack, Inc.

Security class
Series A Common Warrant
Shares / value
2,078
Estimated value
Report date
14 Nov 2024
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.001 per share
Underlying amount
Form 4 holding Director

Glucotrack, Inc.

Security class
Convertible Promissory Note
Shares / value
0
Estimated value
Report date
14 Nov 2024
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.001 per share
Underlying amount
Form 4 holding Director

Glucotrack, Inc.

Security class
Series B Common Warrant
Shares / value
0
Estimated value
Report date
12 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.001 per share
Underlying amount

Transaction history for Erin Catherine Carter in Glucotrack, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .